Advinus Exhibited at the 9th Biosimilars Congregation 2016, Mumbai
Dr. Swati Patel, Group Head, DMPK & CP – Biologics, and Mr. Sushil Momaya – Manager, Business Development represented Advinus at the 9th Biosimilars Congregation 2016 in Mumbai on the 22nd of September. Advinus has evaluated more than a dozen Biosimilars for Toxicology studies for Indian DCGI and global regulatory submissions. Our Biosimilar offerings include Toxicology, Toxicokinetics, Pharmacokinetics, Pharmacodynamics, Biomarker Analysis and Immunogenicity Assessment.